Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Journal of Alzheimer's Disease

ISSN 1387-2877

2 papers in the library · publishing 2019-2020

Papers

The Neuroscience of Meditation by Yi-Yuan Tang and Rongxiang Tang, Academic Press, 2020, 234 pp.

Journal of Alzheimer's Disease September 8, 2020 D. Khalsa

This book critically examines the neuroscience of mindfulness meditation and Mindfulness-Based Stress Reduction (MBSR), arguing that the title is misleading because mindfulness is not synonymous with meditation. It notes that other well-researched techniques, such as Benson's Relaxation Response, Transcendental Meditation, and Kirtan Kriya, are underrepresented. The book covers precision medicine, genetics, nervous system effects, brain regions, personality, and meditation across the lifespan, concluding with future directions. It is a content-dense scientific resource but omits spiritual development and practical meditation instructions.

Resting State Abnormalities of the Default Mode Network in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis

Journal of Alzheimer's Disease June 4, 2019 L. Eyler, J. Elman, S. Hatton et al.

The default mode network (DMN) is often disrupted in Alzheimer's disease (AD), and many studies have examined DMN connectivity in people with mild cognitive impairment (MCI), a presumed AD precursor, to find a biomarker of AD risk. This systematic review and meta-analysis of 57 MCI versus healthy comparison studies found substantial inconsistency: 9 showed no group difference, 8 showed hyperconnectivity in MCI, 22 showed hypoconnectivity, and 18 showed regionally mixed directions. The meta-analysis of 31 studies revealed significant hypo- and hyperconnectivity in MCI, including hypoconnectivity in the posterior cingulate cortex/precuneus. Very few individual studies matched the meta-analytic pattern, and methodological differences did not explain the inconsistencies. No index of DMN connectivity currently qualifies as a useful biomarker of MCI or AD risk.